FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:14-21 July 1, 1999 Number 1 Next

	Full Text PDF Editorial by Thomas, E. D. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background and Methods It is uncertain whether mortality rates among patients who have undergone bone marrow transplantation return to the level of the mortality rates of the general population. We analyzed the characteristics of 6691 patients listed in the International Bone Marrow Transplant Registry. All the patients were free of their original disease two years after allogeneic bone marrow transplantation. Mortality rates in this cohort were compared with those of an age-, sex-, and nationality-matched general population. Cox proportional-hazards regression was used to identify risk factors for death more than two years after transplantation (late death).

Results Among patients who were free of disease two years after transplantation, the probability of living for five more years was 89 percent (95 percent confidence interval, 88 to 90 percent). Among patients who underwent transplantation for aplastic anemia, the risk of death by the sixth year after transplantation did not differ significantly from that of a normal population. Mortality remained significantly higher than normal throughout the study among patients who underwent transplantation for acute lymphoblastic leukemia or chronic myelogenous leukemia and through the ninth year among those who underwent transplantation for acute myelogenous leukemia. Recurrent leukemia was the chief cause of death among patients who received a transplant for leukemia, whereas chronic graft-versus-host disease was the chief cause among those who received a transplant for aplastic anemia. Advanced, long-standing disease before transplantation and active chronic graft-versus-host disease were important risk factors for late death.

Conclusions In patients who receive an allogeneic bone marrow transplant as treatment for acute myelogenous or lymphoblastic leukemia, chronic myelogenous leukemia, or aplastic anemia and who are free of their original disease two years later, the disease is probably cured. However, for many years after transplantation, the mortality among these patients is higher than that in a normal population.

Source Information

From the Service d'Hématologie–Greffe de Moelle, Hôpital Saint Louis, Paris (G.S.); the International Bone Marrow Transplant Registry, Health Policy Institute, Medical College of Wisconsin, Milwaukee (J.V.S., P.A.R., J.P.K.); the College of Medicine, University of Florida, Gainesville (J.R.W.); the Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis (D.W.); the Division of Transplantation Medicine, University of South Carolina, Columbia (P.J.H.-D.); the Department of Medicine, University of Ottawa, Ottawa, Ont., Canada (C.B.); the Service d'Hématologie, Centre Hospitalier Universitaire de Besançon, Besançon, France (J.-Y.C.); the Department of Medicine, Kantonsspital Basel, Basel, Switzerland (J.R.P.); the Department of Internal Medicine, University Hospital, Maastricht, the Netherlands (H.C.S.); and the Department of Hematology, Klinikum Grosshadern, Munich, Germany (H.-J.K.). Other authors were Christine Bender-Götze, M.D., Department of Hematology–Oncology, Kinderpoliklinik, University of Munich, Munich, Germany; Bruce M. Camitta, M.D., Department of Pediatrics, Medical College of Wisconsin, Milwaukee; Kamar Godder, M.D., Division of Transplantation Medicine, University of South Carolina, Columbia; Mary M. Horowitz, M.D., International Bone Marrow Transplant Registry, Health Policy Institute, Medical College of Wisconsin, Milwaukee; and Alan S. Wayne, M.D., Division of Pediatric Hematology–Oncology, University of Miami School of Medicine, Miami.

Address reprint requests to Dr. Mary M. Horowitz at the International Bone Marrow Transplant Registry, Medical College of Wisconsin, 8701 Watertown Plank Rd., P.O. Box 26509, Milwaukee, WI 53226, or at marymh{at}mcw.edu.

Full Text of this Article

Related Letters:

Long-Term Survival after Bone Marrow Transplantation
Oki Y., Kami M., Muto Y., Lounici A., Salmi L. R., Socié G., Klein J. P., Horowitz M. M., The Late Effects Working Committee of the International Bone Marrow Transplant Registry
Extract | Full Text  
N Engl J Med 1999; 341:1394-1395, Oct 28, 1999. Correspondence

This article has been cited by other articles:

• Armenian, S. H., Bhatia, S. (2008). Cardiovascular disease after hematopoietic cell transplantation - lessons learned. haematol 93: 1132-1136 [Full Text]  
• Howard, D. H., Meltzer, D., Kollman, C., Maiers, M., Logan, B., Gragert, L., Setterholm, M., Horowitz, M. M. (2008). Use of Cost-Effectiveness Analysis to Determine Inventory Size for a National Cord Blood Bank. Med Decis Making 28: 243-253 [Abstract]  
• Fujii, H., Cuvelier, G., She, K., Aslanian, S., Shimizu, H., Kariminia, A., Krailo, M., Chen, Z., McMaster, R., Bergman, A., Goldman, F., Grupp, S. A., Wall, D. A., Gilman, A. L., Schultz, K. R. (2008). Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group. Blood 111: 3276-3285 [Abstract] [Full Text]  
• Bhatia, S., Francisco, L., Carter, A., Sun, C.-L., Baker, K. S., Gurney, J. G., McGlave, P. B., Nademanee, A., O'Donnell, M., Ramsay, N. K. C., Robison, L. L., Snyder, D., Stein, A., Forman, S. J., Weisdorf, D. J. (2007). Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110: 3784-3792 [Abstract] [Full Text]  
• Svegliati, S., Olivieri, A., Campelli, N., Luchetti, M., Poloni, A., Trappolini, S., Moroncini, G., Bacigalupo, A., Leoni, P., Avvedimento, E. V., Gabrielli, A. (2007). Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease. Blood 110: 237-241 [Abstract] [Full Text]  
• Shankar, S. M., Carter, A., Sun, C.-L., Francisco, L., Baker, K. S., Gurney, J. G., Weisdorf, D. G., Forman, S. J., Robison, L. L., Grant, M., Bhatia, S. (2007). Health Care Utilization by Adult Long-term Survivors of Hematopoietic Cell Transplant: Report from the Bone Marrow Transplant Survivor Study. Cancer Epidemiol. Biomarkers Prev. 16: 834-839 [Abstract] [Full Text]  
• Sakoda, Y., Hashimoto, D., Asakura, S., Takeuchi, K., Harada, M., Tanimoto, M., Teshima, T. (2007). Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Blood 109: 1756-1764 [Abstract] [Full Text]  
• Socie, G. (2006). Chronic GVHD and health status in long-term survivors. Blood 108: 2503-2504 [Full Text]  
• Fraser, C. J., Bhatia, S., Ness, K., Carter, A., Francisco, L., Arora, M., Parker, P., Forman, S., Weisdorf, D., Gurney, J. G., Baker, K. S. (2006). Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study. Blood 108: 2867-2873 [Abstract] [Full Text]  
• Rovo, A., Tichelli, A., Passweg, J. R., Heim, D., Meyer-Monard, S., Holzgreve, W., Gratwohl, A., De Geyter, C. (2006). Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD. Blood 108: 1100-1105 [Abstract] [Full Text]  
• Couriel, D. R., Hosing, C., Saliba, R., Shpall, E. J., Anderlini, P., Rhodes, B., Smith, V., Khouri, I., Giralt, S., de Lima, M., Hsu, Y., Ghosh, S., Neumann, J., Andersson, B., Qazilbash, M., Hymes, S., Kim, S., Champlin, R., Donato, M. (2006). Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood 107: 3074-3080 [Abstract] [Full Text]  
• Pene, F., Aubron, C., Azoulay, E., Blot, F., Thiery, G., Raynard, B., Schlemmer, B., Nitenberg, G., Buzyn, A., Arnaud, P., Socie, G., Mira, J.-P. (2006). Outcome of Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients: A Reappraisal of Indications for Organ Failure Supports. JCO 24: 643-649 [Abstract] [Full Text]  
• Chalandon, Y., Degermann, S., Villard, J., Arlettaz, L., Kaiser, L., Vischer, S., Walter, S., Heemskerk, M. H. M., van Lier, R. A. W., Helg, C., Chapuis, B., Roosnek, E. (2006). Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications. Blood 107: 389-396 [Abstract] [Full Text]  
• Pavletic, S. Z., Carter, S. L., Kernan, N. A., Henslee-Downey, J., Mendizabal, A. M., Papadopoulos, E., Gingrich, R., Casper, J., Yanovich, S., Weisdorf, D., for the members of the National Heart, Lung, and B, (2005). Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation. Blood 106: 3308-3313 [Abstract] [Full Text]  
• Syrjala, K. L., Langer, S. L., Abrams, J. R., Storer, B. E., Martin, P. J. (2005). Late Effects of Hematopoietic Cell Transplantation Among 10-Year Adult Survivors Compared With Case-Matched Controls. JCO 23: 6596-6606 [Abstract] [Full Text]  
• Ness, K. K., Bhatia, S., Baker, K. S., Francisco, L., Carter, A., Forman, S. J., Robison, L. L., Rosenthal, J., Gurney, J. G. (2005). Performance Limitations and Participation Restrictions Among Childhood Cancer Survivors Treated With Hematopoietic Stem Cell Transplantation: The Bone Marrow Transplant Survivor Study. Arch Pediatr Adolesc Med 159: 706-713 [Abstract] [Full Text]  
• Tomas, L. H. S., Loberiza, F. R. Jr, Klein, J. P., Layde, P. M., Lipchik, R. J., Rizzo, J. D., Bredeson, C. N., Horowitz, M. M. (2005). Risk Factors for Bronchiolitis Obliterans in Allogeneic Hematopoietic Stem-Cell Transplantation for Leukemia. Chest 128: 153-161 [Abstract] [Full Text]  
• Lee, S. J. (2005). New approaches for preventing and treating chronic graft-versus-host disease. Blood 105: 4200-4206 [Abstract] [Full Text]  
• Bhatia, S., Robison, L. L., Francisco, L., Carter, A., Liu, Y., Grant, M., Baker, K. S., Fung, H., Gurney, J. G., McGlave, P. B., Nademanee, A., Ramsay, N. K. C., Stein, A., Weisdorf, D. J., Forman, S. J. (2005). Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 105: 4215-4222 [Abstract] [Full Text]  
• Lee, S., Kim, Y.-J., Min, C.-K., Kim, H.-J., Eom, K.-S., Kim, D.-W., Lee, J.-W., Min, W.-S., Kim, C.-C. (2005). The effect of first-line imatinib interim therapy on the outcome of allogeneic stem cell transplantation in adults with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 105: 3449-3457 [Abstract] [Full Text]  
• Stewart, B. L., Storer, B., Storek, J., Deeg, H. J., Storb, R., Hansen, J. A., Appelbaum, F. R., Carpenter, P. A., Sanders, J. E., Kiem, H.-P., Nash, R. A., Petersdorf, E. W., Moravec, C., Morton, A. J., Anasetti, C., Flowers, M. E. D., Martin, P. J. (2004). Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood 104: 3501-3506 [Abstract] [Full Text]  
• Oeffinger, K. C., Hudson, M. M. (2004). Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors. CA Cancer J Clin 54: 208-236 [Abstract] [Full Text]  
• Syrjala, K. L., Langer, S. L., Abrams, J. R., Storer, B., Sanders, J. E., Flowers, M. E. D., Martin, P. J. (2004). Recovery and Long-term Function After Hematopoietic Cell Transplantation for Leukemia or Lymphoma. JAMA 291: 2335-2343 [Abstract] [Full Text]  
• Leger, C. S., Nevill, T. J. (2004). Hematopoietic stem cell transplantation: a primer for the primary care physician. CMAJ 170: 1569-1577 [Abstract] [Full Text]  
• Ades, L., Mary, J.-Y., Robin, M., Ferry, C., Porcher, R., Esperou, H., Ribaud, P., Devergie, A., Traineau, R., Gluckman, E., Socie, G. (2004). Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood 103: 2490-2497 [Abstract] [Full Text]  
• Peffault de Latour, R., Levy, V., Asselah, T., Marcellin, P., Scieux, C., Ades, L., Traineau, R., Devergie, A., Ribaud, P., Esperou, H., Gluckman, E., Valla, D., Socie, G. (2004). Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood 103: 1618-1624 [Abstract] [Full Text]  
• Vincent, F., Costa, M.-A., Rondeau, E., Socie, G., Tichelli, A. (2003). Chronic renal failure: a nonmalignant late effect of allogeneic stem cell transplantation. Blood 102: 2695-2695 [Full Text]  
• Antin, J. H. (2003). A 41-Year-Old Woman With Chronic Myelogenous Leukemia. JAMA 290: 1083-1090 [Full Text]  
• Seaton, E. D., Szydlo, R. M., Kanfer, E., Apperley, J. F., Russell-Jones, R. (2003). Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 102: 1217-1223 [Abstract] [Full Text]  
• Akpek, G., Lee, S. J., Flowers, M. E., Pavletic, S. Z., Arora, M., Lee, S., Piantadosi, S., Guthrie, K. A., Lynch, J. C., Takatu, A., Horowitz, M. M., Antin, J. H., Weisdorf, D. J., Martin, P. J., Vogelsang, G. B. (2003). Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study. Blood 102: 802-809 [Abstract] [Full Text]  
• Chang, G., McGarigle, C., Koby, D., Antin, J. H. (2003). Symptoms of Pain and Depression in Related Marrow Donors: Changes After Transplant. Psychosomatics 44: 59-64 [Abstract] [Full Text]  
• Lee, S. J., Klein, J. P., Barrett, A. J., Ringden, O., Antin, J. H., Cahn, J.-Y., Carabasi, M. H., Gale, R. P., Giralt, S., Hale, G. A., Ilhan, O., McCarthy, P. L., Socie, G., Verdonck, L. F., Weisdorf, D. J., Horowitz, M. M. (2002). Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 100: 406-414 [Abstract] [Full Text]  
• Min, D., Taylor, P. A., Panoskaltsis-Mortari, A., Chung, B., Danilenko, D. M., Farrell, C., Lacey, D. L., Blazar, B. R., Weinberg, K. I. (2002). Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. Blood 99: 4592-4600 [Abstract] [Full Text]  
• Okamoto, Y., Douek, D. C., McFarland, R. D., Koup, R. A. (2002). Effects of exogenous interleukin-7 on human thymus function. Blood 99: 2851-2858 [Abstract] [Full Text]  
• D'Andrea, A. D., Dahl, N., Guinan, E. C., Shimamura, A. (2002). Marrow Failure. ASH Education Book 2002: 58-72 [Abstract] [Full Text]  
• Maloney, D. G., Sandmaier, B. M., Mackinnon, S., Shizuru, J. A. (2002). Non-Myeloablative Transplantation. ASH Education Book 2002: 392-421 [Abstract] [Full Text]  
• Wingard, J. R., Vogelsang, G. B., Deeg, H. J. (2002). Stem Cell Transplantation: Supportive Care and Long-Term Complications. ASH Education Book 2002: 422-444 [Abstract] [Full Text]  
• Storek, J., Joseph, A., Espino, G., Dawson, M. A., Douek, D. C., Sullivan, K. M., Flowers, M. E. D., Martin, P., Mathioudakis, G., Nash, R. A., Storb, R., Appelbaum, F. R., Maloney, D. G. (2001). Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 98: 3505-3512 [Abstract] [Full Text]  
• Chung, B., Barbara-Burnham, L., Barsky, L., Weinberg, K. (2001). Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation. Blood 98: 1601-1606 [Abstract] [Full Text]  
• Weinberg, K., Blazar, B. R., Wagner, J. E., Agura, E., Hill, B. J., Smogorzewska, M., Koup, R. A., Betts, M. R., Collins, R. H., Douek, D. C. (2001). Factors affecting thymic function after allogeneic hematopoietic stem cell transplantation. Blood 97: 1458-1466 [Abstract] [Full Text]  
• Leung, W., Hudson, M. M., Strickland, D. K., Phipps, S., Srivastava, D. K., Ribeiro, R. C., Rubnitz, J. E., Sandlund, J. T., Kun, L. E., Bowman, L. C., Razzouk, B. I., Mathew, P., Shearer, P., Evans, W. E., Pui, C.-H. (2000). Late Effects of Treatment in Survivors of Childhood Acute Myeloid Leukemia. JCO 18: 3273-3279 [Abstract] [Full Text]  
• Marr, K. A., Seidel, K., Slavin, M. A., Bowden, R. A., Schoch, H. G., Flowers, M. E. D., Corey, L., Boeckh, M. (2000). Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 96: 2055-2061 [Abstract] [Full Text]  
• Roux, E., Dumont-Girard, F., Starobinski, M., Siegrist, C.-A., Helg, C., Chapuis, B., Roosnek, E. (2000). Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 96: 2299-2303 [Abstract] [Full Text]  
• Meyerson, M. (2000). Role of Telomerase in Normal and Cancer Cells. JCO 18: 2626-2634 [Abstract] [Full Text]  
• Kulkarni, S., Powles, R., Treleaven, J., Riley, U., Singhal, S., Horton, C., Sirohi, B., Bhagwati, N., Meller, S., Saso, R., Mehta, J. (2000). Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood 95: 3683-3686 [Abstract] [Full Text]  
• Nietert, P. J., Abboud, M. R., Silverstein, M. D., Jackson, S. M. (2000). Bone marrow transplantation versus periodic prophylactic blood transfusion in sickle cell patients at high risk of ischemic stroke: a decision analysis. Blood 95: 3057-3064 [Abstract] [Full Text]  
• Oki, Y., Kami, M., Muto, Y., Lounici, A., Salmi, L. R., Socie, G., Klein, J. P., Horowitz, M. M., The Late Effects Working Committee of the Internat, (1999). Long-Term Survival after Bone Marrow Transplantation. NEJM 341: 1394-1395 [Full Text]  
• Thomas, E. D. (1999). Does Bone Marrow Transplantation Confer a Normal Life Span?. NEJM 341: 50-51 [Full Text]